Kevin G. Lafond

Overview

Kevin G. Lafond received $348K in total compensation, including $195K in salary, at ZIOPHARM Oncology in 2013.

Source: SEC filing on April 30, 2014.

Related executives

We found ten more executives who work or worked at ZIOPHARM Oncology.

Kevin Boyle

ZIOPHARM Oncology

Chief Executive Officer

Melinda Lackey

ZIOPHARM Oncology

SVP, Legal & Administration

Drew Deniger

ZIOPHARM Oncology

VP, Research and Development

Jonathan Lewis

ZIOPHARM Oncology

Chief Executive Officer

Caesar Belbel

ZIOPHARM Oncology

Chief Legal Officer

Hagop Youssoufian

ZIOPHARM Oncology

Chief Medical Officer

Jason Amello

ZIOPHARM Oncology

Chief Financial Officer

Richard Bagley

ZIOPHARM Oncology

Chief Financial Officer

You may also like